Quanticate, a global data-focused CRO, will relocate its U.S. headquarters from Boston to North Carolina’s Research Triangle. The expansion follows a number of partnerships with pharma companies to provide global functional support, particularly in biostatistics and statistical programming. 

"Due to a number of large-scale partnerships being awarded to Quanticate, we saw the need to expand our U.S. presence and relocate our U.S. headquarters to the Research Triangle,” said Daniel Chapple, Quanticate’s chief commercial officer. “This move provides us with the opportunity of operating within a scalable and growing business region dedicated to the life science industry.”

The relocation is part of a larger global initiative to continue to grow Quanticate’s programming, statistics, medical writing, data management and pharmacovigilance operations.   By moving to a larger location, Quanticate will ramp up its recruitment for its centralized service provision (CSP) approach, utilizing experts, technologies and office locations to provide optimal solutions. 

Quanticate will be opening the North Carolina office in the third quarter of 2013.

Headquartered in the U.K. and U.S., Quanticate primarily focuses on the management, analysis and reporting of data from clinical trials and post-marketing surveillance. Services include scalable on-site and off-site clinical data management, biostatistics, clinical programming, PK/PD analysis, medical writing, pharmacovigilance and consultancy.